Answers
#1 in Business Subscribe Email Print

You are here: Home > Legal > Regulatory Compliance > Corporate Investment with All these Attacking Regulatory Agencies; Why Bother?

Tags

  • involved
  • through
  • tackle
  • developing combination

  • Links

  • Disadvantages of Fast Weight Loss
  • Camping Really Brings People Closer Together
  • How To Get Ahead On A Low Income
  • Answers - Corporate Investment with All these Attacking Regulatory Agencies; Why Bother?

    The government is saying re-invest in America. Pour capital into th
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    e free markets, but why? If they do who will work in the new factor
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ies and plants? Who will work in the new outlets? Who will man the
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    achinery? Unemployment is at a very low number.

    Additionally why i
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    nvest when all you do is add potential lawsuits and liability to yo
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    r company? Indeed, why bother, it is a safer bet for corporations t
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    o hoard cash, enjoy the interest rates or if they decide to expand
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    hen do it away from the over regulation, extortion government lawsu
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    its.

    Invest in other lands and outside the country. But if the oth
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    r nations like China, Mexico, India are risky, then sit on the cash
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    and do nothing that might jeopardize shareholders equity or quarte
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    rly profits. Makes sense right?

    Under their breath and at parties
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    hear whispers; Corporate Investment with All these Attacking Regul
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    atory Agencies; Bite Me. Wow, those are some harsh words, yet this
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    s how they feel and it is hurting America and our economic future.
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    It is time the G-darn government wake up and stop harassing busines
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    people and making false claim and clean up its own act.

    Otherwise
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    the indebted government, which has failed to protect the American
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    eople will have major turnover by The People who own it and the Cor
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    porations who control it. Consider all this in 2006. Vote for Lance


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.answers.org.ua/article/131278/answers-Corporate-Investment-with-All-these-Attacking-Regulatory-Agencies-Why-Bother.html">Corporate Investment with All these Attacking Regulatory Agencies; Why Bother?</a>

    BB link (for phorums):
    [url=http://www.answers.org.ua/article/131278/answers-Corporate-Investment-with-All-these-Attacking-Regulatory-Agencies-Why-Bother.html]Corporate Investment with All these Attacking Regulatory Agencies; Why Bother?[/url]

    Related Articles:

    Is the Back of Your Business Card Blank?

    How To Create An Info Product To Sell On eBay Quick & Easy

    Get A Credit Card With A Low Interest Rate

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com